Israel Englander Harmony Biosciences Holdings, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 6,333 shares of HRMY stock, worth $216,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,333

Previous 70,811 91.06%

Holding current value

$216,461

Previous $2.83 Million 92.33%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.86 - $41.49 $2.05 Million - $2.68 Million	-64,478 Reduced 91.06%	6,333 $217,000
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $7.1 Million - $9.45 Million	-236,609 Reduced 76.97%	70,811 $2.83 Million
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $3.02 Million - $3.46 Million	104,691 Added 51.64%	307,420 $9.27 Million
Q1 2024 May 15, 2024	BUY	$29.93 - $35.06 $5.4 Million - $6.32 Million	180,294 Added 803.63%	202,729 $6.81 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $8.95 Million - $15.7 Million	-465,965 Reduced 95.41%	22,435 $724,000
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $1.38 Million - $1.7 Million	45,368 Added 10.24%	488,400 $17.2 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $8.32 Million - $14.6 Million	270,102 Added 156.19%	443,032 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $6.58 Million - $8.83 Million	144,976 Added 518.62%	172,930 $9.53 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $1.18 Million - $1.55 Million	27,954 New	27,954 $1.24 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $492,467 - $765,718	-14,683 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $144,291 - $222,620	4,354 Added 42.15%	14,683 $714,000
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $1.48 Million - $1.9 Million	-43,333 Reduced 80.75%	10,329 $440,000
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $2.45 Million - $3.68 Million	-95,261 Reduced 63.97%	53,662 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $3.67 Million - $4.72 Million	141,270 Added 1845.94%	148,923 $4.2 Million
Q1 2021 May 17, 2021	SELL	$27.56 - $40.37 $3.78 Million - $5.53 Million	-137,010 Reduced 94.71%	7,653 $253,000
Q4 2020 Feb 16, 2021	SELL	$31.74 - $51.34 $8.56 Million - $13.8 Million	-269,624 Reduced 65.08%	144,663 $5.23 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $12.8 Million - $18.4 Million	414,287 New	414,287 $14 Million

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.6M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account